Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorUniversity Hospital, Toulouse
About this trial
BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.
Eligibility criteria
Qualifiers
Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture or
Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route or
Patient with pancreatic adenocarcinoma proven histologically and/or cytologically
Disqualifiers
Patient with a pancreatic tumor whose analysis histological is not an adenocarcinoma
Pregnant or breastfeeding patient
Trial design
Treatments tested in this trial
- collection of biological samples
Treatment groups
No treatment groups listed
Locations
8Béthune hospital center62408, Béthune France
Haut-Lévêque Hospital33604, Bordeaux France
Huriez Hospital59037, Lille France
Jean Mermoz private hosptila69008, Lyon France
Sponsors and collaborators
University Hospital, Toulouse
Lead sponsor
Source ClinicalTrials.gov